Pet Medication Comprehensive Study by Type (Antibiotics, Antimicrobials, Antiparasitics, Chemotherapeutics), Application (Cat, Dog, Horse, Fish, Other), Distribution Channel (Online Channel, Offline Channel) Players and Region - Global Market Outlook to 2030

Pet Medication Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Pet Medication
Pet is an animal kept primarily for a person's company or entertainment rather than as a working animal, livestock or a laboratory animal. Pet medications are used to manage, treat or cure the pet's medical conditions. Antibiotics, non-steroidal anti-inflammatories, opioid pain relievers, antiparasitics, chemotherapeutics and others.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Zoetis Inc. (United States), Merck & Co., Inc. (United States), Merial (France), Elanco Animal Health (United States), Bayer (Germany), C.H. Boehringer Sohn AG & Ko. KG (Germany), Novartis (Switzerland), Virbac (France), Vetoquinol (France) and Nexvet (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Kindred Biosciences (United States) and Entest Biomedical (United States).

Segmentation Overview
AMA Research has segmented the market of Global Pet Medication market by Type (Antibiotics, Antimicrobials, Antiparasitics and Chemotherapeutics), Application (Cat, Dog, Horse, Fish and Other) and Region.



On the basis of geography, the market of Pet Medication has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online Channel will boost the Pet Medication market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Awareness about Pet Health

Market Growth Drivers:
Increased Adoption of Pets and Rising number of Pet Physicians

Challenges:
Stringent Rules and Regulations

Restraints:
Side Effects of the Pets

Opportunities:
Growing Pet Pharmacies Worldwide and Growing Number of E-Pharmacies

Market Leaders and their expansionary development strategies
In November 2018, Zoetis Inc. and Abaxis, Inc. has announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services. The acquisition is expected to enhance Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years



Key Target Audience
Pet Medication Manufacturers, Raw Material Suppliers, Distributors, Research Professionals, Distributors and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Antibiotics
  • Antimicrobials
  • Antiparasitics
  • Chemotherapeutics
By Application
  • Cat
  • Dog
  • Horse
  • Fish
  • Other
By Distribution Channel
  • Online Channel
  • Offline Channel

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Adoption of Pets
      • 3.2.2. Rising number of Pet Physicians
    • 3.3. Market Challenges
      • 3.3.1. Stringent Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Growing Awareness about Pet Health
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pet Medication, by Type, Application, Distribution Channel and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Pet Medication (Value)
      • 5.2.1. Global Pet Medication by: Type (Value)
        • 5.2.1.1. Antibiotics
        • 5.2.1.2. Antimicrobials
        • 5.2.1.3. Antiparasitics
        • 5.2.1.4. Chemotherapeutics
      • 5.2.2. Global Pet Medication by: Application (Value)
        • 5.2.2.1. Cat
        • 5.2.2.2. Dog
        • 5.2.2.3. Horse
        • 5.2.2.4. Fish
        • 5.2.2.5. Other
      • 5.2.3. Global Pet Medication by: Distribution Channel (Value)
        • 5.2.3.1. Online Channel
        • 5.2.3.2. Offline Channel
      • 5.2.4. Global Pet Medication Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pet Medication (Volume)
      • 5.3.1. Global Pet Medication by: Type (Volume)
        • 5.3.1.1. Antibiotics
        • 5.3.1.2. Antimicrobials
        • 5.3.1.3. Antiparasitics
        • 5.3.1.4. Chemotherapeutics
      • 5.3.2. Global Pet Medication by: Application (Volume)
        • 5.3.2.1. Cat
        • 5.3.2.2. Dog
        • 5.3.2.3. Horse
        • 5.3.2.4. Fish
        • 5.3.2.5. Other
      • 5.3.3. Global Pet Medication by: Distribution Channel (Volume)
        • 5.3.3.1. Online Channel
        • 5.3.3.2. Offline Channel
      • 5.3.4. Global Pet Medication Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Pet Medication (Price)
      • 5.4.1. Global Pet Medication by: Type (Price)
  • 6. Pet Medication: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co., Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merial (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco Animal Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. C.H. Boehringer Sohn AG & Ko. KG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Virbac (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Vetoquinol (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nexvet (Australia)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pet Medication Sale, by Type, Application, Distribution Channel and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Pet Medication (Value)
      • 7.2.1. Global Pet Medication by: Type (Value)
        • 7.2.1.1. Antibiotics
        • 7.2.1.2. Antimicrobials
        • 7.2.1.3. Antiparasitics
        • 7.2.1.4. Chemotherapeutics
      • 7.2.2. Global Pet Medication by: Application (Value)
        • 7.2.2.1. Cat
        • 7.2.2.2. Dog
        • 7.2.2.3. Horse
        • 7.2.2.4. Fish
        • 7.2.2.5. Other
      • 7.2.3. Global Pet Medication by: Distribution Channel (Value)
        • 7.2.3.1. Online Channel
        • 7.2.3.2. Offline Channel
      • 7.2.4. Global Pet Medication Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pet Medication (Volume)
      • 7.3.1. Global Pet Medication by: Type (Volume)
        • 7.3.1.1. Antibiotics
        • 7.3.1.2. Antimicrobials
        • 7.3.1.3. Antiparasitics
        • 7.3.1.4. Chemotherapeutics
      • 7.3.2. Global Pet Medication by: Application (Volume)
        • 7.3.2.1. Cat
        • 7.3.2.2. Dog
        • 7.3.2.3. Horse
        • 7.3.2.4. Fish
        • 7.3.2.5. Other
      • 7.3.3. Global Pet Medication by: Distribution Channel (Volume)
        • 7.3.3.1. Online Channel
        • 7.3.3.2. Offline Channel
      • 7.3.4. Global Pet Medication Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Pet Medication (Price)
      • 7.4.1. Global Pet Medication by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pet Medication: by Type(USD Million)
  • Table 2. Pet Medication Antibiotics , by Region USD Million (2018-2023)
  • Table 3. Pet Medication Antimicrobials , by Region USD Million (2018-2023)
  • Table 4. Pet Medication Antiparasitics , by Region USD Million (2018-2023)
  • Table 5. Pet Medication Chemotherapeutics , by Region USD Million (2018-2023)
  • Table 6. Pet Medication: by Application(USD Million)
  • Table 7. Pet Medication Cat , by Region USD Million (2018-2023)
  • Table 8. Pet Medication Dog , by Region USD Million (2018-2023)
  • Table 9. Pet Medication Horse , by Region USD Million (2018-2023)
  • Table 10. Pet Medication Fish , by Region USD Million (2018-2023)
  • Table 11. Pet Medication Other , by Region USD Million (2018-2023)
  • Table 12. Pet Medication: by Distribution Channel(USD Million)
  • Table 13. Pet Medication Online Channel , by Region USD Million (2018-2023)
  • Table 14. Pet Medication Offline Channel , by Region USD Million (2018-2023)
  • Table 15. South America Pet Medication, by Country USD Million (2018-2023)
  • Table 16. South America Pet Medication, by Type USD Million (2018-2023)
  • Table 17. South America Pet Medication, by Application USD Million (2018-2023)
  • Table 18. South America Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 19. Brazil Pet Medication, by Type USD Million (2018-2023)
  • Table 20. Brazil Pet Medication, by Application USD Million (2018-2023)
  • Table 21. Brazil Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 22. Argentina Pet Medication, by Type USD Million (2018-2023)
  • Table 23. Argentina Pet Medication, by Application USD Million (2018-2023)
  • Table 24. Argentina Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 25. Rest of South America Pet Medication, by Type USD Million (2018-2023)
  • Table 26. Rest of South America Pet Medication, by Application USD Million (2018-2023)
  • Table 27. Rest of South America Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 28. Asia Pacific Pet Medication, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Pet Medication, by Type USD Million (2018-2023)
  • Table 30. Asia Pacific Pet Medication, by Application USD Million (2018-2023)
  • Table 31. Asia Pacific Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 32. China Pet Medication, by Type USD Million (2018-2023)
  • Table 33. China Pet Medication, by Application USD Million (2018-2023)
  • Table 34. China Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 35. Japan Pet Medication, by Type USD Million (2018-2023)
  • Table 36. Japan Pet Medication, by Application USD Million (2018-2023)
  • Table 37. Japan Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 38. India Pet Medication, by Type USD Million (2018-2023)
  • Table 39. India Pet Medication, by Application USD Million (2018-2023)
  • Table 40. India Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 41. South Korea Pet Medication, by Type USD Million (2018-2023)
  • Table 42. South Korea Pet Medication, by Application USD Million (2018-2023)
  • Table 43. South Korea Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 44. Taiwan Pet Medication, by Type USD Million (2018-2023)
  • Table 45. Taiwan Pet Medication, by Application USD Million (2018-2023)
  • Table 46. Taiwan Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 47. Australia Pet Medication, by Type USD Million (2018-2023)
  • Table 48. Australia Pet Medication, by Application USD Million (2018-2023)
  • Table 49. Australia Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Pet Medication, by Type USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Pet Medication, by Application USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 53. Europe Pet Medication, by Country USD Million (2018-2023)
  • Table 54. Europe Pet Medication, by Type USD Million (2018-2023)
  • Table 55. Europe Pet Medication, by Application USD Million (2018-2023)
  • Table 56. Europe Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 57. Germany Pet Medication, by Type USD Million (2018-2023)
  • Table 58. Germany Pet Medication, by Application USD Million (2018-2023)
  • Table 59. Germany Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 60. France Pet Medication, by Type USD Million (2018-2023)
  • Table 61. France Pet Medication, by Application USD Million (2018-2023)
  • Table 62. France Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 63. Italy Pet Medication, by Type USD Million (2018-2023)
  • Table 64. Italy Pet Medication, by Application USD Million (2018-2023)
  • Table 65. Italy Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 66. United Kingdom Pet Medication, by Type USD Million (2018-2023)
  • Table 67. United Kingdom Pet Medication, by Application USD Million (2018-2023)
  • Table 68. United Kingdom Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 69. Netherlands Pet Medication, by Type USD Million (2018-2023)
  • Table 70. Netherlands Pet Medication, by Application USD Million (2018-2023)
  • Table 71. Netherlands Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 72. Rest of Europe Pet Medication, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Pet Medication, by Application USD Million (2018-2023)
  • Table 74. Rest of Europe Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 75. MEA Pet Medication, by Country USD Million (2018-2023)
  • Table 76. MEA Pet Medication, by Type USD Million (2018-2023)
  • Table 77. MEA Pet Medication, by Application USD Million (2018-2023)
  • Table 78. MEA Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 79. Middle East Pet Medication, by Type USD Million (2018-2023)
  • Table 80. Middle East Pet Medication, by Application USD Million (2018-2023)
  • Table 81. Middle East Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 82. Africa Pet Medication, by Type USD Million (2018-2023)
  • Table 83. Africa Pet Medication, by Application USD Million (2018-2023)
  • Table 84. Africa Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 85. North America Pet Medication, by Country USD Million (2018-2023)
  • Table 86. North America Pet Medication, by Type USD Million (2018-2023)
  • Table 87. North America Pet Medication, by Application USD Million (2018-2023)
  • Table 88. North America Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 89. United States Pet Medication, by Type USD Million (2018-2023)
  • Table 90. United States Pet Medication, by Application USD Million (2018-2023)
  • Table 91. United States Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 92. Canada Pet Medication, by Type USD Million (2018-2023)
  • Table 93. Canada Pet Medication, by Application USD Million (2018-2023)
  • Table 94. Canada Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 95. Mexico Pet Medication, by Type USD Million (2018-2023)
  • Table 96. Mexico Pet Medication, by Application USD Million (2018-2023)
  • Table 97. Mexico Pet Medication, by Distribution Channel USD Million (2018-2023)
  • Table 98. Pet Medication Sales: by Type(K Units)
  • Table 99. Pet Medication Sales Antibiotics , by Region K Units (2018-2023)
  • Table 100. Pet Medication Sales Antimicrobials , by Region K Units (2018-2023)
  • Table 101. Pet Medication Sales Antiparasitics , by Region K Units (2018-2023)
  • Table 102. Pet Medication Sales Chemotherapeutics , by Region K Units (2018-2023)
  • Table 103. Pet Medication Sales: by Application(K Units)
  • Table 104. Pet Medication Sales Cat , by Region K Units (2018-2023)
  • Table 105. Pet Medication Sales Dog , by Region K Units (2018-2023)
  • Table 106. Pet Medication Sales Horse , by Region K Units (2018-2023)
  • Table 107. Pet Medication Sales Fish , by Region K Units (2018-2023)
  • Table 108. Pet Medication Sales Other , by Region K Units (2018-2023)
  • Table 109. Pet Medication Sales: by Distribution Channel(K Units)
  • Table 110. Pet Medication Sales Online Channel , by Region K Units (2018-2023)
  • Table 111. Pet Medication Sales Offline Channel , by Region K Units (2018-2023)
  • Table 112. South America Pet Medication Sales, by Country K Units (2018-2023)
  • Table 113. South America Pet Medication Sales, by Type K Units (2018-2023)
  • Table 114. South America Pet Medication Sales, by Application K Units (2018-2023)
  • Table 115. South America Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 116. Brazil Pet Medication Sales, by Type K Units (2018-2023)
  • Table 117. Brazil Pet Medication Sales, by Application K Units (2018-2023)
  • Table 118. Brazil Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 119. Argentina Pet Medication Sales, by Type K Units (2018-2023)
  • Table 120. Argentina Pet Medication Sales, by Application K Units (2018-2023)
  • Table 121. Argentina Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 122. Rest of South America Pet Medication Sales, by Type K Units (2018-2023)
  • Table 123. Rest of South America Pet Medication Sales, by Application K Units (2018-2023)
  • Table 124. Rest of South America Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 125. Asia Pacific Pet Medication Sales, by Country K Units (2018-2023)
  • Table 126. Asia Pacific Pet Medication Sales, by Type K Units (2018-2023)
  • Table 127. Asia Pacific Pet Medication Sales, by Application K Units (2018-2023)
  • Table 128. Asia Pacific Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 129. China Pet Medication Sales, by Type K Units (2018-2023)
  • Table 130. China Pet Medication Sales, by Application K Units (2018-2023)
  • Table 131. China Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 132. Japan Pet Medication Sales, by Type K Units (2018-2023)
  • Table 133. Japan Pet Medication Sales, by Application K Units (2018-2023)
  • Table 134. Japan Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 135. India Pet Medication Sales, by Type K Units (2018-2023)
  • Table 136. India Pet Medication Sales, by Application K Units (2018-2023)
  • Table 137. India Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 138. South Korea Pet Medication Sales, by Type K Units (2018-2023)
  • Table 139. South Korea Pet Medication Sales, by Application K Units (2018-2023)
  • Table 140. South Korea Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 141. Taiwan Pet Medication Sales, by Type K Units (2018-2023)
  • Table 142. Taiwan Pet Medication Sales, by Application K Units (2018-2023)
  • Table 143. Taiwan Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 144. Australia Pet Medication Sales, by Type K Units (2018-2023)
  • Table 145. Australia Pet Medication Sales, by Application K Units (2018-2023)
  • Table 146. Australia Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 147. Rest of Asia-Pacific Pet Medication Sales, by Type K Units (2018-2023)
  • Table 148. Rest of Asia-Pacific Pet Medication Sales, by Application K Units (2018-2023)
  • Table 149. Rest of Asia-Pacific Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 150. Europe Pet Medication Sales, by Country K Units (2018-2023)
  • Table 151. Europe Pet Medication Sales, by Type K Units (2018-2023)
  • Table 152. Europe Pet Medication Sales, by Application K Units (2018-2023)
  • Table 153. Europe Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 154. Germany Pet Medication Sales, by Type K Units (2018-2023)
  • Table 155. Germany Pet Medication Sales, by Application K Units (2018-2023)
  • Table 156. Germany Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 157. France Pet Medication Sales, by Type K Units (2018-2023)
  • Table 158. France Pet Medication Sales, by Application K Units (2018-2023)
  • Table 159. France Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 160. Italy Pet Medication Sales, by Type K Units (2018-2023)
  • Table 161. Italy Pet Medication Sales, by Application K Units (2018-2023)
  • Table 162. Italy Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 163. United Kingdom Pet Medication Sales, by Type K Units (2018-2023)
  • Table 164. United Kingdom Pet Medication Sales, by Application K Units (2018-2023)
  • Table 165. United Kingdom Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 166. Netherlands Pet Medication Sales, by Type K Units (2018-2023)
  • Table 167. Netherlands Pet Medication Sales, by Application K Units (2018-2023)
  • Table 168. Netherlands Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 169. Rest of Europe Pet Medication Sales, by Type K Units (2018-2023)
  • Table 170. Rest of Europe Pet Medication Sales, by Application K Units (2018-2023)
  • Table 171. Rest of Europe Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 172. MEA Pet Medication Sales, by Country K Units (2018-2023)
  • Table 173. MEA Pet Medication Sales, by Type K Units (2018-2023)
  • Table 174. MEA Pet Medication Sales, by Application K Units (2018-2023)
  • Table 175. MEA Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 176. Middle East Pet Medication Sales, by Type K Units (2018-2023)
  • Table 177. Middle East Pet Medication Sales, by Application K Units (2018-2023)
  • Table 178. Middle East Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 179. Africa Pet Medication Sales, by Type K Units (2018-2023)
  • Table 180. Africa Pet Medication Sales, by Application K Units (2018-2023)
  • Table 181. Africa Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 182. North America Pet Medication Sales, by Country K Units (2018-2023)
  • Table 183. North America Pet Medication Sales, by Type K Units (2018-2023)
  • Table 184. North America Pet Medication Sales, by Application K Units (2018-2023)
  • Table 185. North America Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 186. United States Pet Medication Sales, by Type K Units (2018-2023)
  • Table 187. United States Pet Medication Sales, by Application K Units (2018-2023)
  • Table 188. United States Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 189. Canada Pet Medication Sales, by Type K Units (2018-2023)
  • Table 190. Canada Pet Medication Sales, by Application K Units (2018-2023)
  • Table 191. Canada Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 192. Mexico Pet Medication Sales, by Type K Units (2018-2023)
  • Table 193. Mexico Pet Medication Sales, by Application K Units (2018-2023)
  • Table 194. Mexico Pet Medication Sales, by Distribution Channel K Units (2018-2023)
  • Table 195. Pet Medication: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Pet Medication: by Type(USD Million)
  • Table 207. Pet Medication Antibiotics , by Region USD Million (2025-2030)
  • Table 208. Pet Medication Antimicrobials , by Region USD Million (2025-2030)
  • Table 209. Pet Medication Antiparasitics , by Region USD Million (2025-2030)
  • Table 210. Pet Medication Chemotherapeutics , by Region USD Million (2025-2030)
  • Table 211. Pet Medication: by Application(USD Million)
  • Table 212. Pet Medication Cat , by Region USD Million (2025-2030)
  • Table 213. Pet Medication Dog , by Region USD Million (2025-2030)
  • Table 214. Pet Medication Horse , by Region USD Million (2025-2030)
  • Table 215. Pet Medication Fish , by Region USD Million (2025-2030)
  • Table 216. Pet Medication Other , by Region USD Million (2025-2030)
  • Table 217. Pet Medication: by Distribution Channel(USD Million)
  • Table 218. Pet Medication Online Channel , by Region USD Million (2025-2030)
  • Table 219. Pet Medication Offline Channel , by Region USD Million (2025-2030)
  • Table 220. South America Pet Medication, by Country USD Million (2025-2030)
  • Table 221. South America Pet Medication, by Type USD Million (2025-2030)
  • Table 222. South America Pet Medication, by Application USD Million (2025-2030)
  • Table 223. South America Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 224. Brazil Pet Medication, by Type USD Million (2025-2030)
  • Table 225. Brazil Pet Medication, by Application USD Million (2025-2030)
  • Table 226. Brazil Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 227. Argentina Pet Medication, by Type USD Million (2025-2030)
  • Table 228. Argentina Pet Medication, by Application USD Million (2025-2030)
  • Table 229. Argentina Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 230. Rest of South America Pet Medication, by Type USD Million (2025-2030)
  • Table 231. Rest of South America Pet Medication, by Application USD Million (2025-2030)
  • Table 232. Rest of South America Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 233. Asia Pacific Pet Medication, by Country USD Million (2025-2030)
  • Table 234. Asia Pacific Pet Medication, by Type USD Million (2025-2030)
  • Table 235. Asia Pacific Pet Medication, by Application USD Million (2025-2030)
  • Table 236. Asia Pacific Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 237. China Pet Medication, by Type USD Million (2025-2030)
  • Table 238. China Pet Medication, by Application USD Million (2025-2030)
  • Table 239. China Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 240. Japan Pet Medication, by Type USD Million (2025-2030)
  • Table 241. Japan Pet Medication, by Application USD Million (2025-2030)
  • Table 242. Japan Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 243. India Pet Medication, by Type USD Million (2025-2030)
  • Table 244. India Pet Medication, by Application USD Million (2025-2030)
  • Table 245. India Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 246. South Korea Pet Medication, by Type USD Million (2025-2030)
  • Table 247. South Korea Pet Medication, by Application USD Million (2025-2030)
  • Table 248. South Korea Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 249. Taiwan Pet Medication, by Type USD Million (2025-2030)
  • Table 250. Taiwan Pet Medication, by Application USD Million (2025-2030)
  • Table 251. Taiwan Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 252. Australia Pet Medication, by Type USD Million (2025-2030)
  • Table 253. Australia Pet Medication, by Application USD Million (2025-2030)
  • Table 254. Australia Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Pet Medication, by Type USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Pet Medication, by Application USD Million (2025-2030)
  • Table 257. Rest of Asia-Pacific Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 258. Europe Pet Medication, by Country USD Million (2025-2030)
  • Table 259. Europe Pet Medication, by Type USD Million (2025-2030)
  • Table 260. Europe Pet Medication, by Application USD Million (2025-2030)
  • Table 261. Europe Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 262. Germany Pet Medication, by Type USD Million (2025-2030)
  • Table 263. Germany Pet Medication, by Application USD Million (2025-2030)
  • Table 264. Germany Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 265. France Pet Medication, by Type USD Million (2025-2030)
  • Table 266. France Pet Medication, by Application USD Million (2025-2030)
  • Table 267. France Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 268. Italy Pet Medication, by Type USD Million (2025-2030)
  • Table 269. Italy Pet Medication, by Application USD Million (2025-2030)
  • Table 270. Italy Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 271. United Kingdom Pet Medication, by Type USD Million (2025-2030)
  • Table 272. United Kingdom Pet Medication, by Application USD Million (2025-2030)
  • Table 273. United Kingdom Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 274. Netherlands Pet Medication, by Type USD Million (2025-2030)
  • Table 275. Netherlands Pet Medication, by Application USD Million (2025-2030)
  • Table 276. Netherlands Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 277. Rest of Europe Pet Medication, by Type USD Million (2025-2030)
  • Table 278. Rest of Europe Pet Medication, by Application USD Million (2025-2030)
  • Table 279. Rest of Europe Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 280. MEA Pet Medication, by Country USD Million (2025-2030)
  • Table 281. MEA Pet Medication, by Type USD Million (2025-2030)
  • Table 282. MEA Pet Medication, by Application USD Million (2025-2030)
  • Table 283. MEA Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 284. Middle East Pet Medication, by Type USD Million (2025-2030)
  • Table 285. Middle East Pet Medication, by Application USD Million (2025-2030)
  • Table 286. Middle East Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 287. Africa Pet Medication, by Type USD Million (2025-2030)
  • Table 288. Africa Pet Medication, by Application USD Million (2025-2030)
  • Table 289. Africa Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 290. North America Pet Medication, by Country USD Million (2025-2030)
  • Table 291. North America Pet Medication, by Type USD Million (2025-2030)
  • Table 292. North America Pet Medication, by Application USD Million (2025-2030)
  • Table 293. North America Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 294. United States Pet Medication, by Type USD Million (2025-2030)
  • Table 295. United States Pet Medication, by Application USD Million (2025-2030)
  • Table 296. United States Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 297. Canada Pet Medication, by Type USD Million (2025-2030)
  • Table 298. Canada Pet Medication, by Application USD Million (2025-2030)
  • Table 299. Canada Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 300. Mexico Pet Medication, by Type USD Million (2025-2030)
  • Table 301. Mexico Pet Medication, by Application USD Million (2025-2030)
  • Table 302. Mexico Pet Medication, by Distribution Channel USD Million (2025-2030)
  • Table 303. Pet Medication Sales: by Type(K Units)
  • Table 304. Pet Medication Sales Antibiotics , by Region K Units (2025-2030)
  • Table 305. Pet Medication Sales Antimicrobials , by Region K Units (2025-2030)
  • Table 306. Pet Medication Sales Antiparasitics , by Region K Units (2025-2030)
  • Table 307. Pet Medication Sales Chemotherapeutics , by Region K Units (2025-2030)
  • Table 308. Pet Medication Sales: by Application(K Units)
  • Table 309. Pet Medication Sales Cat , by Region K Units (2025-2030)
  • Table 310. Pet Medication Sales Dog , by Region K Units (2025-2030)
  • Table 311. Pet Medication Sales Horse , by Region K Units (2025-2030)
  • Table 312. Pet Medication Sales Fish , by Region K Units (2025-2030)
  • Table 313. Pet Medication Sales Other , by Region K Units (2025-2030)
  • Table 314. Pet Medication Sales: by Distribution Channel(K Units)
  • Table 315. Pet Medication Sales Online Channel , by Region K Units (2025-2030)
  • Table 316. Pet Medication Sales Offline Channel , by Region K Units (2025-2030)
  • Table 317. South America Pet Medication Sales, by Country K Units (2025-2030)
  • Table 318. South America Pet Medication Sales, by Type K Units (2025-2030)
  • Table 319. South America Pet Medication Sales, by Application K Units (2025-2030)
  • Table 320. South America Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 321. Brazil Pet Medication Sales, by Type K Units (2025-2030)
  • Table 322. Brazil Pet Medication Sales, by Application K Units (2025-2030)
  • Table 323. Brazil Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 324. Argentina Pet Medication Sales, by Type K Units (2025-2030)
  • Table 325. Argentina Pet Medication Sales, by Application K Units (2025-2030)
  • Table 326. Argentina Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 327. Rest of South America Pet Medication Sales, by Type K Units (2025-2030)
  • Table 328. Rest of South America Pet Medication Sales, by Application K Units (2025-2030)
  • Table 329. Rest of South America Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 330. Asia Pacific Pet Medication Sales, by Country K Units (2025-2030)
  • Table 331. Asia Pacific Pet Medication Sales, by Type K Units (2025-2030)
  • Table 332. Asia Pacific Pet Medication Sales, by Application K Units (2025-2030)
  • Table 333. Asia Pacific Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 334. China Pet Medication Sales, by Type K Units (2025-2030)
  • Table 335. China Pet Medication Sales, by Application K Units (2025-2030)
  • Table 336. China Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 337. Japan Pet Medication Sales, by Type K Units (2025-2030)
  • Table 338. Japan Pet Medication Sales, by Application K Units (2025-2030)
  • Table 339. Japan Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 340. India Pet Medication Sales, by Type K Units (2025-2030)
  • Table 341. India Pet Medication Sales, by Application K Units (2025-2030)
  • Table 342. India Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 343. South Korea Pet Medication Sales, by Type K Units (2025-2030)
  • Table 344. South Korea Pet Medication Sales, by Application K Units (2025-2030)
  • Table 345. South Korea Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 346. Taiwan Pet Medication Sales, by Type K Units (2025-2030)
  • Table 347. Taiwan Pet Medication Sales, by Application K Units (2025-2030)
  • Table 348. Taiwan Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 349. Australia Pet Medication Sales, by Type K Units (2025-2030)
  • Table 350. Australia Pet Medication Sales, by Application K Units (2025-2030)
  • Table 351. Australia Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 352. Rest of Asia-Pacific Pet Medication Sales, by Type K Units (2025-2030)
  • Table 353. Rest of Asia-Pacific Pet Medication Sales, by Application K Units (2025-2030)
  • Table 354. Rest of Asia-Pacific Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 355. Europe Pet Medication Sales, by Country K Units (2025-2030)
  • Table 356. Europe Pet Medication Sales, by Type K Units (2025-2030)
  • Table 357. Europe Pet Medication Sales, by Application K Units (2025-2030)
  • Table 358. Europe Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 359. Germany Pet Medication Sales, by Type K Units (2025-2030)
  • Table 360. Germany Pet Medication Sales, by Application K Units (2025-2030)
  • Table 361. Germany Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 362. France Pet Medication Sales, by Type K Units (2025-2030)
  • Table 363. France Pet Medication Sales, by Application K Units (2025-2030)
  • Table 364. France Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 365. Italy Pet Medication Sales, by Type K Units (2025-2030)
  • Table 366. Italy Pet Medication Sales, by Application K Units (2025-2030)
  • Table 367. Italy Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 368. United Kingdom Pet Medication Sales, by Type K Units (2025-2030)
  • Table 369. United Kingdom Pet Medication Sales, by Application K Units (2025-2030)
  • Table 370. United Kingdom Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 371. Netherlands Pet Medication Sales, by Type K Units (2025-2030)
  • Table 372. Netherlands Pet Medication Sales, by Application K Units (2025-2030)
  • Table 373. Netherlands Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 374. Rest of Europe Pet Medication Sales, by Type K Units (2025-2030)
  • Table 375. Rest of Europe Pet Medication Sales, by Application K Units (2025-2030)
  • Table 376. Rest of Europe Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 377. MEA Pet Medication Sales, by Country K Units (2025-2030)
  • Table 378. MEA Pet Medication Sales, by Type K Units (2025-2030)
  • Table 379. MEA Pet Medication Sales, by Application K Units (2025-2030)
  • Table 380. MEA Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 381. Middle East Pet Medication Sales, by Type K Units (2025-2030)
  • Table 382. Middle East Pet Medication Sales, by Application K Units (2025-2030)
  • Table 383. Middle East Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 384. Africa Pet Medication Sales, by Type K Units (2025-2030)
  • Table 385. Africa Pet Medication Sales, by Application K Units (2025-2030)
  • Table 386. Africa Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 387. North America Pet Medication Sales, by Country K Units (2025-2030)
  • Table 388. North America Pet Medication Sales, by Type K Units (2025-2030)
  • Table 389. North America Pet Medication Sales, by Application K Units (2025-2030)
  • Table 390. North America Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 391. United States Pet Medication Sales, by Type K Units (2025-2030)
  • Table 392. United States Pet Medication Sales, by Application K Units (2025-2030)
  • Table 393. United States Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 394. Canada Pet Medication Sales, by Type K Units (2025-2030)
  • Table 395. Canada Pet Medication Sales, by Application K Units (2025-2030)
  • Table 396. Canada Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 397. Mexico Pet Medication Sales, by Type K Units (2025-2030)
  • Table 398. Mexico Pet Medication Sales, by Application K Units (2025-2030)
  • Table 399. Mexico Pet Medication Sales, by Distribution Channel K Units (2025-2030)
  • Table 400. Pet Medication: by Type(USD/Units)
  • Table 401. Research Programs/Design for This Report
  • Table 402. Key Data Information from Secondary Sources
  • Table 403. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pet Medication: by Type USD Million (2018-2023)
  • Figure 5. Global Pet Medication: by Application USD Million (2018-2023)
  • Figure 6. Global Pet Medication: by Distribution Channel USD Million (2018-2023)
  • Figure 7. South America Pet Medication Share (%), by Country
  • Figure 8. Asia Pacific Pet Medication Share (%), by Country
  • Figure 9. Europe Pet Medication Share (%), by Country
  • Figure 10. MEA Pet Medication Share (%), by Country
  • Figure 11. North America Pet Medication Share (%), by Country
  • Figure 12. Global Pet Medication: by Type K Units (2018-2023)
  • Figure 13. Global Pet Medication: by Application K Units (2018-2023)
  • Figure 14. Global Pet Medication: by Distribution Channel K Units (2018-2023)
  • Figure 15. South America Pet Medication Share (%), by Country
  • Figure 16. Asia Pacific Pet Medication Share (%), by Country
  • Figure 17. Europe Pet Medication Share (%), by Country
  • Figure 18. MEA Pet Medication Share (%), by Country
  • Figure 19. North America Pet Medication Share (%), by Country
  • Figure 20. Global Pet Medication: by Type USD/Units (2018-2023)
  • Figure 21. Global Pet Medication share by Players 2023 (%)
  • Figure 22. Global Pet Medication share by Players (Top 3) 2023(%)
  • Figure 23. Global Pet Medication share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zoetis Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Merial (France) Revenue, Net Income and Gross profit
  • Figure 30. Merial (France) Revenue: by Geography 2023
  • Figure 31. Elanco Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 32. Elanco Animal Health (United States) Revenue: by Geography 2023
  • Figure 33. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bayer (Germany) Revenue: by Geography 2023
  • Figure 35. C.H. Boehringer Sohn AG & Ko. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 36. C.H. Boehringer Sohn AG & Ko. KG (Germany) Revenue: by Geography 2023
  • Figure 37. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Novartis (Switzerland) Revenue: by Geography 2023
  • Figure 39. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 40. Virbac (France) Revenue: by Geography 2023
  • Figure 41. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 42. Vetoquinol (France) Revenue: by Geography 2023
  • Figure 43. Nexvet (Australia) Revenue, Net Income and Gross profit
  • Figure 44. Nexvet (Australia) Revenue: by Geography 2023
  • Figure 45. Global Pet Medication: by Type USD Million (2025-2030)
  • Figure 46. Global Pet Medication: by Application USD Million (2025-2030)
  • Figure 47. Global Pet Medication: by Distribution Channel USD Million (2025-2030)
  • Figure 48. South America Pet Medication Share (%), by Country
  • Figure 49. Asia Pacific Pet Medication Share (%), by Country
  • Figure 50. Europe Pet Medication Share (%), by Country
  • Figure 51. MEA Pet Medication Share (%), by Country
  • Figure 52. North America Pet Medication Share (%), by Country
  • Figure 53. Global Pet Medication: by Type K Units (2025-2030)
  • Figure 54. Global Pet Medication: by Application K Units (2025-2030)
  • Figure 55. Global Pet Medication: by Distribution Channel K Units (2025-2030)
  • Figure 56. South America Pet Medication Share (%), by Country
  • Figure 57. Asia Pacific Pet Medication Share (%), by Country
  • Figure 58. Europe Pet Medication Share (%), by Country
  • Figure 59. MEA Pet Medication Share (%), by Country
  • Figure 60. North America Pet Medication Share (%), by Country
  • Figure 61. Global Pet Medication: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Zoetis Inc. (United States)
  • Merck & Co., Inc. (United States)
  • Merial (France)
  • Elanco Animal Health (United States)
  • Bayer (Germany)
  • C.H. Boehringer Sohn AG & Ko. KG (Germany)
  • Novartis (Switzerland)
  • Virbac (France)
  • Vetoquinol (France)
  • Nexvet (Australia)
Additional players considered in the study are as follows:
Kindred Biosciences (United States) , Entest Biomedical (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 226 Pages 86 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Zoetis Inc. (United States), Merck & Co., Inc. (United States), Merial (France), Elanco Animal Health (United States), Bayer (Germany), C.H. Boehringer Sohn AG & Ko. KG (Germany), Novartis (Switzerland), Virbac (France), Vetoquinol (France) and Nexvet (Australia) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Awareness about Pet Health" is seen as one of major influencing trends for Pet Medication Market during projected period 2023-2030.
The Pet Medication market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Pet Medication research Report?